D. Gordon Strickland - Jan 27, 2022 Form 4 Insider Report for NeuroBo Pharmaceuticals, Inc. (NRBO)

Role
Director
Signature
/s/ Jeffrey Kuras, by Power of Attorney
Stock symbol
NRBO
Transactions as of
Jan 27, 2022
Transactions value $
$0
Form type
4
Date filed
2/2/2022, 04:51 PM
Next filing
Jun 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRBO Non-qualified Stock Option (right to buy) Award $0 +40K $0.00 40K Jan 27, 2022 Common Stock 40K $1.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests in thirty-six equal monthly installments beginning on the one-month anniversary of the date of grant, subject to the reporting person's continued service through each applicable vesting date.

Remarks:

Exhibit 24, Power of Attorney, is attached.